Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction notice to "Identification of cardiotoxic targets of doxorubicin via network toxicology and development of exosome-based delivery system for osteosarcoma therapy" [Int. Immunopharmacol. 161 (2025) 115011].

International immunopharmacology·2026
Same author

Exploring the Therapeutic Mechanisms of Fangfeng Decoction for Rheumatoid Arthritis via Integrated Pharmacological, Lactylation, and Genetic Approaches.

Journal of ethnopharmacology·2026
Same author

Retraction notice to "Engineered Exosomes Loaded with Triptolide: An Innovative Approach to Enhance Therapeutic Efficacy in Rheumatoid Arthritis" [Int. Immunopharmacol. 129 (2024) 111677].

International immunopharmacology·2026
Same author

Boosting Oral Chemotherapy Efficacy and Ameliorating Intestinal Dysbiosis via a Microfluidic-Engineered RGD-Targeted Nanoplatform against Breast Cancer.

Molecular pharmaceutics·2025
Same author

Extraction of anthocyanins from purple sweet potato: evaluation of anti-inflammatory effects in a rheumatoid arthritis animal model, mechanistic studies on inflammatory cells, and development of exosome-based delivery for enhanced targeting.

Frontiers in immunology·2025
Same author

Identification of cardiotoxic targets of doxorubicin via network toxicology and development of exosome-based delivery system for osteosarcoma therapy.

International immunopharmacology·2025

Related Experiment Video

Updated: Jun 24, 2025

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
14:10

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation

Published on: December 15, 2010

16.0K

Crafting Docetaxel-Loaded Albumin Nanoparticles Through a Novel Thermal-Driven Self-Assembly/Microfluidic Combination

Juan Du1, Li-Li Shi2, Wei-Wei Jiang3

  • 1Department of Pharmacy, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, People's Republic of China.

International Journal of Nanomedicine
|June 7, 2024
PubMed
Summary

Novel bovine serum albumin nanoparticles (DTX-BSA-NPs) offer a stable, surfactant-free alternative to commercial docetaxel (DTX) formulations. This new method improves drug bioavailability and reduces side effects, addressing key challenges in nanoparticle development.

Keywords:
DTX-BSA nanoparticlesin-vitro releasemicrofluidic technologypharmacokineticsthermal-driven self-assembly

More Related Videos

Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation
06:57

Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation

Published on: August 11, 2018

7.9K
Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
09:41

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

23.0K

Related Experiment Videos

Last Updated: Jun 24, 2025

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
14:10

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation

Published on: December 15, 2010

16.0K
Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation
06:57

Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation

Published on: August 11, 2018

7.9K
Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
09:41

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

23.0K

Area of Science:

  • Nanotechnology
  • Materials Science
  • Pharmaceutical Sciences

Background:

  • Commercial docetaxel (DTX) formulations cause severe side effects due to polysorbate 80 and ethanol.
  • Novel surfactant-free nanoparticle (NP) systems are needed to improve bioavailability and reduce side effects.
  • Controlling NP particle size, stability, and batch-to-batch variation are major challenges.

Purpose of the Study:

  • To prepare docetaxel-loaded bovine serum albumin nanoparticles (DTX-BSA-NPs) using a novel thermal-driven self-assembly/microfluidic technology.
  • To optimize the formulation and preparation process of DTX-BSA-NPs for improved particle size, encapsulation efficiency (EE), and drug loading (DL).
  • To evaluate the drug release, physicochemical properties, stability, and pharmacokinetics of the developed NPs.

Main Methods:

  • DTX-BSA-NPs were prepared using a combination of thermal-driven self-assembly and microfluidic technology.
  • Single-factor analysis and orthogonal tests were employed to optimize NP formulation and preparation parameters.
  • Drug release, physicochemical properties, stability, and pharmacokinetic profiles were assessed.

Main Results:

  • Optimized DTX-BSA-NPs exhibited uniform particle size (118.30 nm), high EE (89.04%), and DL (8.27%).
  • Sustained drug release (70% over 96 hours) and enhanced stability were observed.
  • DTX-BSA-NPs demonstrated improved pharmacokinetic parameters, including increased half-life, mean residence time, and AUC, with decreased plasma clearance compared to DTX.

Conclusions:

  • The thermal-driven self-assembly/microfluidic method effectively produces BSA-based NPs.
  • These NPs improve the bioavailability and stability of docetaxel.
  • DTX-BSA-NPs represent a promising alternative to traditional docetaxel formulations.